About Us

At Ajinomoto Health & Nutrition, we are making significant advances in food and health with new ideas and innovative technologies. We are seeking candidates with energy and enthusiasm to be part of our growing team throughout North America. As an Ajinomoto Health & Nutrition employee, you are part of a diverse, innovative, and collaborative community committed to enhancing lives through nutrition and health. Our team is committed to providing amino acid-based solutions that create better lives for all.

We do not use AI to screen applications. Applications and resumes of qualified applicants are reviewed by a real person because we value your time and believe each qualified applicant deserves thoughtful, human consideration. It’s an old‑fashioned approach—done with purpose.

Why Join Us

Our people are the key ingredient to our success. We offer a collaborative, innovative environment where you can grow your career and make an impact on global food and health solutions.

We provide a comprehensive and competitive total rewards package, including:

• Competitive Pay and Annual Bonus Opportunity• 401(k) with Company Contributions • Medical, Dental, and Vision — Effective Day 1• Paid Time Off, Company Holidays, and Floating Holidays

• Paid Parental Leave• Wellness Programs and Yearly Wellness Reimbursement• Work Flexibility• Company-Paid Life and Disability Insurance• Employee Assistance Program (EAP)• Tuition Reimbursement Opportunities• Career Growth and Development within a Global Organization

• Company-Provided Mental Health and Caregiving support

Overview

Our intern program is designed to individuals who are currently enrolled full-time students at an accredited four-year college or university. Work is project oriented and will include design & implementation of engineered plans for the production process.The goal is to provide a structured program that will equip interns with the skills and experience to help prepare for a successful career.

Qualifications

EDUCATION, CERTIFICATIONS AND EXPERIENCE: · Currently enrolled at an accredited four-year college or university seeking a Bachelor of Science in Chemical Engineering, Mechanical Engineering, Manufacturing Engineering, or related field · Minimum of 3.0 GPA · Must be authorized to work in the U.S.

KNOWLEDGE, SKILLS AND ABILITIES: · Must be able to work 20 – 29 hours per week · Demonstrated verbal and written communication skills to be effective · Microsoft Office experience required · Must be a self-starter and like working in a team environment as well as ability to leverage scientific knowledge and theory to practical applications · Strong planning and organizational skills · Able to research and analyze information of considerable difficulty and draw valid conclusions · Able to build relationships across all organizational lines · Able to develop and maintain awareness of occupational hazards and safety precautions

Working Conditions / Physical Requirements

WORKING CONDITIONS: · Manufacturing environment that is hot and humid · May need to work outside in various temperatures · Fast paced manufacturing environment working both in office and plant settings. · May perform activities in an environment containing hazardous elements and requiring safety awareness and adherence to all safety policies and guidelines · Work must be performed in a safe manner for personal protection and for the protection of other team members · All safety procedures, procedures described in SOPs, BPRs, and support the compliance of applicable ISO standards in all functional areas must be followed, enforced, and strictly complied with

PHYSICAL REQUIREMENTS: · Sitting, standing, walking, repetitive use of hands/arms/legs, and eye/hand coordination for 6+ hours a day · Occasional bending, reaching overhead, crouching, balancing, pushing, or pulling · Occasional need to lift up to 50 lbs. · Walking required, usually < 1-2 hours a day. · Occasional bending, reaching overhead, crouching, balancing, pushing, or pulling. · Must be able to wear all PPE that is required

Responsibilities

Provide technical support to assigned area(s) · Work closely with process/production engineers and Operations personnel on specific assignments related to meeting daily production goals · Design both plant process and equipment to be readily adapted to suit the product range and the process technologies involved; taking safety, environmental, and economic aspects into account · Assessing multiple options for plant improvements, including design, budget, schedule, and economic return. · Project Management including Installing and commissioning new production and /or equipment, monitoring developments and troubleshooting; applying new technologies; ensuring that potential safety issues related to the project operator, the environment, the process, and the product are considered at all stages. · Maintain integrity and reputation through compliance with state, federal and AJICO guidelines and regulations · Work collaboratively with team members with different backgrounds and perspectives · Assists other employees in accomplishments of company goals · Follows instructions and performs other duties as may be assigned by supervisor · Participates in and completes company-required training programs

Salary Range

$18.00 to $22.00

EEO Statement

Ajinomoto is an Equal Opportunity Employer and does not discriminate on the basis of race, religion, color, sex, age, physical or mental disability, national origin, veteran status or any other basis protected by state, federal, or local law. All employment is decided on the basis of qualifications, merit, and business need.

About the company

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify's Take

What believers are saying

June 22, 2026 Syntax Bio collaboration expands StemFit into cell-therapy development.
February 11, 2025 LabCentral sponsorship improves access to biotech startups and founders.
June 4, 2025 Raleigh lab renovation supports larger API volumes and stricter quality control.

What critics are saying

Ajinomoto Foods North America’s March 2026 glass recall damaged North America brand trust.
Thermo Fisher, Merck, Lonza, and Cytiva crowd stem-cell media, squeezing pricing.
If StemFit stays niche, AHN remains dependent on low-volume specialty wins by 2027.

What makes Ajinomoto Health & Nutrition North America unique

StemFit™ gives AHN chemically defined stem-cell media for regenerative medicine workflows.
Raleigh QC lab upgrade on June 4, 2025 strengthened API quality and scale.
Ajinomoto’s amino-acid fermentation heritage anchors AHN’s formulation and manufacturing discipline.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
Paid Holidays
Parental Leave
Flexible Work Hours
Wellness Program
Life Insurance
Disability Insurance
Tuition Reimbursement
Mental Health Support

Company News

Business Wire

Jun 22nd, 2026

Syntax Bio, Ajinomoto Health & Nutrition North America, Inc. collaborate to evaluate stem cell culture technologies using Cellgorithm(TM) platform.

Syntax Bio, Ajinomoto Health & Nutrition North America, Inc. collaborate to evaluate stem cell culture technologies using Cellgorithm(TM) platform. The collaboration will evaluate Ajinomoto Group's stem cell culture products using Syntax Bio's programmable stem cell differentiation platform to support improved regenerative medicine discovery, development, and manufacturing. CHICAGO & ITASCA, Ill.-(BUSINESS WIRE)-Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture innovation and part of Ajinomoto Group, today announced a collaboration to evaluate Ajinomoto Group's StemFit(TM) stem cell culture products using Syntax Bio's proprietary Cellgorithm(TM) platform. Syntax Bio and Ajinomoto Health & Nutrition North America are collaborating to evaluate stem cell culture technologies that could enhance the performance, consistency and scalability of regenerative medicine discovery, development and manufacturing. Share Through the collaboration, AHN is providing Syntax Bio with StemFit(TM) stem cell culture media products to demonstrate Cellgorithm(TM) compatibility, performance and workflow optimization. Syntax Bio will evaluate StemFit(TM) and generate data to support their growing pipeline of cell therapy collaborations. "We are excited to support Syntax Bio's innovative approach to stem cell differentiation," said Michael Lish, President & CEO of Ajinomoto Health & Nutrition North America, Inc. "StemFit(TM) provides a highly controlled and reliable culture environment that is well-suited to complement advanced platforms like Cellgorithm(TM). By supporting a smooth transition from research workflows and potentially toward manufacturing applications, we believe our solutions can help accelerate the development of next-generation cell therapies." "The development of cell therapies depends on having compatible and reproducible technologies across every stage of the workflow, including the environments used to grow and maintain cells," said John Craighead, Ph.D., CEO of Syntax Bio. "Collaborating with Ajinomoto Group gives us the opportunity to evaluate high-performance stem cell culture products using our Cellgorithm(TM) platform to enhance efficiency, consistency, and scale across many regenerative medicine applications." Cellgorithm(TM) technology simplifies stem cell differentiation by programming the sequence of gene activations needed to create specific cell types. The platform reduces the need for repeated manual interventions and has demonstrated the ability to generate target cell types in days or weeks rather than months. Through collaborations with innovators such as Syntax Bio, Ajinomoto Group aims to explore expanding the use of StemFit(TM) into more advanced cell development and potential future manufacturing processes. This initiative supports the company's broader goal of advancing regenerative medicine with high-quality solutions that improve reliability, safety, and scalability across cell therapy development and production. About Syntax Bio Syntax Bio is a synthetic biology company programming the next generation of cell therapies. Its proprietary Cellgorithm(TM) platform uses a CRISPR-based system to program and accelerate stem cell differentiation, transforming how regenerative medicines are discovered, developed, and manufactured. By replacing slow, labor-intensive differentiation processes with a rapid, programmable approach that mimics human development, Syntax Bio makes cellular generation more reliable and scalable at unprecedented speed, unlocking new possibilities across the biotechnology industry. Learn more at www.syntaxbio.com. About Ajinomoto Health & Nutrition North America, Inc. Ajinomoto Health & Nutrition North America, Inc. is a wholly-owned subsidiary of Ajinomoto Group, a global leader in amino acid science and the research, development, manufacture, and sale of amino acid-based products across pharmaceutical, nutraceutical, sports nutrition, health and beauty, and food industries. Building on its long-standing expertise in amino acid technologies, the company is advancing regenerative medicine by providing high-quality, chemically defined stem cell culture media, including the StemFit(TM) series, which supports the development of safe, reliable, and scalable cell therapies. For additional information, please visit www.ajihealthandnutrition.com. Contacts. Ajinomoto Health & Nutrition North America, Inc. Kimberly Kennedy [email protected] More News From Syntax Bio CHICAGO-( BUSINESS WIRE )-Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of directors and scientific advisory board. The expansion brings Syntax Bio's Series A to $14.4 million and total funding to over $25 million. The expanded round builds on support from Astellas Venture Management, Illumina Ventures, DCVC Bio, Civilization Ventures, EGB Capital, Mansu... CHICAGO-( BUSINESS WIRE )-Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on advancing stem cell-derived pancreatic cell therapies for type 1 diabetes. Under the collaboration, the teams seek to define and develop an allogeneic pancreatic beta cell therapy for insulin-dependent diabetes based on patient needs. Syntax Bio plans to use its proprietary CellgorithmTM platform to gui... CHICAGO & NEW YORK-( BUSINESS WIRE )-Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced it has received an award of up to $856,250 from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, under its Industry Discovery and Development Partnership (IDDP) program to advance a pancreatic beta cell therapy targeting T1D using its Cellgorithm platform technology. "The daily burden for those living with t...

PR Newswire

Jun 4th, 2025

Ajinomoto Health Nutrition North America, Inc. Opens Quality Control Laboratory Following $2.1M Renovation

RALEIGH, N.C., June 4, 2025 /PRNewswire/ -- Ajinomoto Health & Nutrition North America, Inc. (AHN), a global leader in amino acid manufacturing, celebrated the opening of its renovated Quality Control Laboratory today with a ribbon-cutting ceremony.Global senior leaders and dedicated team members who have been integral to the renovation efforts gathered at the modern facility on AHN's Raleigh, North Carolina, campus. The re-envisioned lab showcases AHN's commitment to delivering top product quality and leading safety standards."By updating our facilities, we are even more equipped to meet the evolving needs of our customers and maintain our position as a leader in the industry," said Jessica Lee, Quality Manager. "Our Quality Control Laboratory is part of Ajinomoto Health and Nutrition's ongoing investment in quality and innovation."With the expanding need for amino acids in today's market, AHN's Quality Control Laboratory features advanced analytical equipment, improved workflow efficiencies, and enhanced safety measures. The facility benefits from Raleigh's skilled workforce, top universities, and numerous life sciences support companies, strengthening the area's reputation as a leading biotech hub.The enhancements also support AHN's growth plan for supplying Active Pharmaceutical Ingredient (API) amino acids and blends globally.By investing in these upgrades, AHN is positioning itself to meet the increasing global demand for high-quality APIs. The improved laboratory enables AHN to scale production and maintain stringent quality standards across larger volumes

PR Newswire

Feb 11th, 2025

Ajinomoto Co., Inc., Through Its Subsidiary Ajinomoto Health Nutrition North America, Inc., Announces Gold Sponsorship Of Labcentral: Accelerating Innovation In Biotechnology

CAMBRIDGE, Mass., Feb. 11, 2025 /PRNewswire/ -- Ajinomoto Co., Inc., a global leader in biotechnology and food innovation, proudly announces its sponsorship of LabCentral, a premier launchpad for high-potential life sciences and biotech startups located in the heart of the Greater Boston biotechnology community. This partnership underscores the Ajinomoto Group's commitment to fostering innovation, collaboration, and scientific advancement in this rapidly evolving sector and thriving ecosystem.The sponsorship is in full alignment with the Ajinomoto Group's purpose to contribute to the well-being of all human beings, our society, and our planet with "AminoScience" and its cutting-edge technologies, including innovations in cell and gene therapy, amino acid, and protein sciences. The Ajinomoto Innovation Strategy Development Team in particular is fully committed to supporting the thriving biotech ecosystem in Cambridge and Massachusetts.LabCentral, located in Cambridge, provides startups with the laboratory space, resources, and community necessary to translate breakthrough ideas into viable solutions. The Ajinomoto Group's sponsorship will enhance LabCentral's ability to support promising ventures in areas such as drug discovery, cell and gene therapy, and other transformative life sciences fields."LabCentral represents the nexus of innovation and opportunity in biotech, and the Ajinomoto Group is honored to support its mission of empowering next-generation startups," said Dr. Ikuo Kira, Executive Officer & Vice President, General Manager, North America Division

AgFunder

Jul 31st, 2024

Shiru And Ajinomoto Team Up On Ai-Powered Sweet Protein Discovery Journey

Protein discovery startup Shiru has teamed up with Ajinomoto Health Nutrition Partners, part of ingredients giant Ajinomoto, to develop and commercialize sweet proteins: high intensity natural sweeteners that can replace sugar in beverages and other products. Natural sweeteners such as stevia and monk fruit have improved significantly in recent years. However, sweet proteins—which are found in fruits and berries that grow near the equator and can be up to 5,000x sweeter than sugar with no impact on blood glucose—add an exciting new dimension to the natural sugar-reduction toolbox, Shiru founder and CEO Dr. Jasmin Hume told AgFunderNews. The challenge, she says, has been two-fold. First, identifying proteins in nature with the right kind of sweetness (without linger, stability issues, etc)

vegconom GmbH